Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

Meliha C Kapetanovic; Lars Erik Kristensen; Tore Saxne; Teodora Aktas; Andreas Mörner; Pierre Geborek

doi:10.1186/ar4427

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

Meliha C Kapetanovic, Lars Erik Kristensen, Tore Saxne, Teodora Aktas, Andreas Mörner, Pierre Geborek

Rheumatology

Research output: Contribution to journal › Article › peer-review

167 Downloads (Pure)

Abstract

An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix®) was reported as highly immunogenic resulting in seroconversion in 77 to 94% of adults after administration of a single dose. The aim of the study was to investigate the impact of different anti-rheumatic treatments on antibody response to pH1N1 vaccination in patients with rheumatoid arthritis (RA) and spondylarthropathy (SpA).

Original language	English
Article number	R2
Journal	Arthritis Research and Therapy
Volume	16
Issue number	1
DOIs	https://doi.org/10.1186/ar4427
Publication status	Published - 2014

Subject classification (UKÄ)

Rheumatology and Autoimmunity

Access to Document

10.1186/ar4427

BMC__Kapetanovic_et_al

http://www.ncbi.nlm.nih.gov/pubmed/24383620?dopt=Abstract

Cite this

@article{e28af2a419f642929285830f38d894e5,

title = "Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.",

abstract = "An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix{\textregistered}) was reported as highly immunogenic resulting in seroconversion in 77 to 94% of adults after administration of a single dose. The aim of the study was to investigate the impact of different anti-rheumatic treatments on antibody response to pH1N1 vaccination in patients with rheumatoid arthritis (RA) and spondylarthropathy (SpA).",

author = "{C Kapetanovic}, Meliha and Kristensen, {Lars Erik} and Tore Saxne and Teodora Aktas and Andreas M{\"o}rner and Pierre Geborek",

year = "2014",

doi = "10.1186/ar4427",

language = "English",

volume = "16",

journal = "Arthritis Research & Therapy",

issn = "1478-6354",

publisher = "BioMed Central (BMC)",

number = "1",

}

TY - JOUR

T1 - Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

AU - C Kapetanovic, Meliha

AU - Kristensen, Lars Erik

AU - Saxne, Tore

AU - Aktas, Teodora

AU - Mörner, Andreas

AU - Geborek, Pierre

PY - 2014

Y1 - 2014

N2 - An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix®) was reported as highly immunogenic resulting in seroconversion in 77 to 94% of adults after administration of a single dose. The aim of the study was to investigate the impact of different anti-rheumatic treatments on antibody response to pH1N1 vaccination in patients with rheumatoid arthritis (RA) and spondylarthropathy (SpA).

AB - An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix®) was reported as highly immunogenic resulting in seroconversion in 77 to 94% of adults after administration of a single dose. The aim of the study was to investigate the impact of different anti-rheumatic treatments on antibody response to pH1N1 vaccination in patients with rheumatoid arthritis (RA) and spondylarthropathy (SpA).

U2 - 10.1186/ar4427

DO - 10.1186/ar4427

M3 - Article

C2 - 24383620

VL - 16

JO - Arthritis Research & Therapy

JF - Arthritis Research & Therapy

SN - 1478-6354

IS - 1

M1 - R2

ER -

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this